Overview of Histasin

Property	Description
Active ingredient	Cetirizine Hydrochloride
Form	Oral tablet, Oral solution (syrup/liquid)
Pharmacological class	Second-generation H1-receptor antagonist
Common use	Symptomatic relief of allergic discomfort
Origin	Synthetic compound (Piperazine derivative)

Histasin is a medicinal product defined by its single active ingredient, Cetirizine Hydrochloride. It is scientifically categorized as a Histamine H1 Antagonist, a class of medicine commonly used for the symptomatic relief of allergies.

What Type of Medicine is Histasin?

Histasin is classified as a second-generation H1-receptor antagonist, distinguishing it from older compounds by its increased peripheral selectivity. The compound is a synthetic piperazine derivative. Its classification as a second-generation agent means it is designed to preferentially target peripheral receptors outside the brain, giving it the characteristic of having a low potential for sedation compared to first-generation antihistamines. The medication is intended for oral administration and is widely available in many regions as an over-the-counter (OTC) product.

Composition and Available Forms

The therapeutic action of Histasin is exclusively provided by the Cetirizine Hydrochloride active component, making it a single-ingredient product. This substance acts as the sole therapeutic agent, combined with pharmaceutically inert base materials that create the final dosage forms. Histasin is typically available as an oral tablet and an oral solution (liquid/syrup) for systemic use. The liquid oral solution is often specially formulated to facilitate administration in patient groups who may struggle with swallowing solid tablets.

Histasin’s General Purpose

The fundamental purpose of Histasin is to provide symptomatic relief by blocking the effects of histamine, a chemical released by the body during an allergic reaction. Antihistamines like Cetirizine work by blocking the action of this substance, which is responsible for causing classic allergic symptoms. This selective histamine blockade at the peripheral H1 receptors is clinically recognized for its ability to effectively mitigate the range of physical discomforts, including sneezing, nasal discharge, itchy or watery eyes, and the irritation associated with allergic skin reactions.

What side effects are possible with Histasin?

Possible Side Effects and Safety Information

Adverse reactions to Histasin (Cetirizine Hydrochloride) are formally classified by official regulatory bodies based on their frequency in clinical trials and post-marketing reports. The most Common reactions, which may affect more than 1 in 100 people, typically include Somnolence (drowsiness), Fatigue, Headache, and Dry Mouth, primarily involving the Nervous System and Gastrointestinal System organ classes.

Less frequently observed reactions are classified as Uncommon (e.g., Agitation, Diarrhea) or Rare (e.g., Insomnia, Hypersensitivity). The label documents specific Serious Adverse Reactions, including Anaphylactic Shock and Convulsions, although these are classified as Very Rare events, occurring in less than 1 in 10,000 patients.

Safety notes specify that effects like drowsiness may be more noticeable at the start of treatment. Additionally, caution is advised regarding activities requiring full mental alertness, such as driving, if somnolence occurs. The official safety profile also highlights the risk of severe pruritus (itching) or hives upon discontinuation after long-term daily use.

Population-specific constraints mandate dose adjustments for individuals with moderate to severe Renal Impairment. The medication is officially contraindicated in patients with severe kidney problems (creatinine clearance less than 10 mL/min) and caution is advised in those with predisposing factors for Urinary Retention.

Overdose and Emergency Response

Histasin Overdose and when to seek help

Documented Overdose Manifestations The officially documented clinical signs of overdose primarily involve the Central Nervous System and Autonomic systems. Manifestations commonly reported in regulatory sources include somnolence (drowsiness), agitation, confusion, tachycardia (fast heart rate), urinary retention, mydriasis (dilated pupils), and headache. Severe outcomes documented include the potential for seizures and profound CNS depression that can lead to stupor or coma at high exposures. Due to cardiovascular risks, cardiac monitoring may be required for large-dose exposures.

Immediate Emergency Response Regulatory authorities mandate that individuals seek immediate medical attention for any suspected overdose of Histasin. Emergency services or a poison control center must be contacted immediately if severe symptoms, such as collapse, trouble breathing, or a seizure, are observed.

Supportive Management and Population Notes No specific antidote is known for the management of Histasin overdose; therefore, treatment is strictly symptomatic and supportive. While procedures like activated charcoal may be considered to limit absorption, official labeling states that the substance is not effectively removed by dialysis. Population notes indicate that children may initially present with paradoxical agitation or restlessness before significant drowsiness occurs. Older adults are also noted to be at increased risk for effects such as heightened confusion.

Therapeutic Uses of Histasin

Histasin (Cetirizine) is commonly used across domains where additional symptomatic support is needed, addressing conditions characterized by periods of heightened symptoms. Its use is considered relevant for the management of two primary conditions: allergic rhinitis and chronic urticaria.

This medication is applied in addressing symptom clusters associated with heightened physiological activity, helping manage manifestations like frequent sneezing, runny nose, and irritating watery or itchy eyes, as well as persistent skin itching (pruritus) and hives. It is commonly used when short-term symptomatic assistance is needed, often applied during phases when symptoms become more noticeable due to allergen exposure.

“Histasin supports patients during episodes of heightened discomfort by easing the overall symptom load.”

The medication is relevant in conditions presenting with systemic or localized discomfort, assisting with maintaining functional stability when symptoms interfere with routine activities. It contributes to improved comfort during symptomatic periods across both seasonal allergy flares and recurrent or episodic manifestations of skin discomfort.

Quick Fact: Symptom Management for Pruritus and Hives

Histasin is relevant for managing the disruptive pruritus (itching) and visible manifestations of hives (weals) in patients with acute or chronic urticaria, providing support that helps ease the overall symptom burden.

Regulatory References

NIH StatPearls overview on Cetirizine

Eligibility and Restrictions for Use

Histasin (Cetirizine) eligibility is determined by specific regulatory criteria regarding age, hypersensitivity, and organ function status.

Who Must Not Use Histasin (Contraindications)

Use is strictly contraindicated in patients with a known hypersensitivity to the active substance, any excipients, or structurally related compounds such as hydroxyzine or any piperazine derivatives. The medicine is also prohibited for individuals with severe renal impairment (Creatinine Clearance below 10 mL/min).

Age-Group Eligibility

Histasin is approved for use in adults and adolescents (ge 12 years). Paediatric use is approved for children 6 to 11 years (tablet and liquid forms) and 2 to 5 years (liquid forms only). Safety and efficacy are not established for infants less than 6 months of age.

Restricted or Conditional Use

Use is restricted and requires consideration for adjustment in adults and adolescents with moderate renal impairment or hepatic impairment. Additionally, caution is recommended for patients with a predisposition to urinary retention or those who are epileptic or at risk of convulsions.

Pregnancy and Lactation

Based on regulatory review, use during pregnancy and lactation is generally considered acceptable when clinically necessary.

What should I know about interactions with other medicines?

Histasin (Cetirizine Hydrochloride) has officially documented interaction patterns that fall into distinct regulatory categories, encompassing drug–drug, drug–substance, and procedural interactions.

Pharmacodynamic and Substance Interactions

Co-administration with alcohol or other CNS depressants is documented to result in a pharmacodynamic additive effect, which may lead to additional reductions in alertness and impairment of performance. The regulatory profile notes that intake with food decreases the rate of absorption (time to peak concentration) but does not alter the overall extent of absorption.

Pharmacokinetic and Medicinal Product Interactions

The xanthine derivative Theophylline, when administered at a dose of 400 mg once daily, formally caused a 16% decrease in the clearance of Histasin, leading to potentially increased plasma exposure. Regulatory studies have documented that no clinically significant pharmacokinetic interactions were observed with Azithromycin, Erythromycin, Ketoconazole, or Pseudoephedrine. Histasin is classified as a substrate for the P-glycoprotein (P-gp) efflux transporter.

Restrictions and Procedural Constraints

Use of Histasin is contraindicated in patients with severe renal impairment (e.g., creatinine clearance <15 ml/min) due to the significant risk of drug accumulation. A specific procedural timing restriction is mandated: Histasin must be discontinued for three days prior to having an allergy skin test, as the medication inhibits the official test response.

Mechanism of Action

Selective H1-Receptor Targeting

Histasin is an inhibitor that selectively binds to the Histamine H1-receptor in the central nervous system. This highly specific binding event initiates an inverse agonism, which induces a conformational change that reduces the receptor's constitutive activity. This action results in the stabilization of the H1-receptor in an inactive state.

Intracellular Cascade and Pathway Modulation

The inverse agonism at the H1-receptor results in a corresponding diminution of the downstream Gq signaling cascade. By altering the activity of this pathway, Histasin modulates neuronal circuits and signaling pathways that are intrinsically implicated in the regulation of the sleep-wake cycle.

Dosage and Administration Information

Administration Overview

Histasin is typically administered orally. Consistency in the timing of the dose and the method of intake is often recommended to maintain stable levels of the medication in the body.

Methods of Intake

With or Without Food: The medication can generally be taken regardless of meal times. However, if gastrointestinal upset occurs, taking the dose with food or a glass of milk may help improve tolerance.
Formulations: Depending on the specific preparation, Histasin may be available as tablets, capsules, or liquid solutions.
- Solid Dosage Forms: Tablets and capsules should be swallowed whole with water. Crushing or chewing should be avoided unless specifically indicated by the formulation type.
- Liquid Forms: Liquid preparations should be measured with a standardized measuring device to ensure an accurate volume.

General Considerations for Use

Proper storage and handling are essential for maintaining the integrity of the medication. It should be kept in its original packaging, protected from direct sunlight, and stored in a cool, dry environment.

Patients should follow the specific guidance provided by their healthcare professional regarding the duration of use. If a dose is not taken at the scheduled time, it is standard practice to return to the regular schedule rather than attempting to compensate for the omission.

Recent Clinical Evidence

Histasin: Recent Clinical Evidence

This overview summarizes the available research on Histasin (Cetirizine Hydrochloride), focusing on the types of clinical studies that have been conducted, the outcomes researchers measured, and the known limitations or gaps in the evidence, as reported by authoritative scientific sources. The text below describes the evidence base but does not provide clinical advice or treatment recommendations.

Evidence for the Study of Allergic Rhinitis

Histasin was studied in research exploring symptoms associated with allergic rhinitis, which includes both seasonal and perennial allergies. The primary research for this involves numerous Randomized Controlled Trials (RCTs). In these research scenarios, Histasin was observed alongside a placebo (an inactive pill) and in research settings with other treatment methods. These studies focused on outcomes related to physical discomfort, specifically evaluating the measured intensity and frequency of symptoms like sneezing and itchy eyes, often quantified using a Total Symptom Score (TSS). Findings indicate patterns related to the measured outcomes in the Histasin group compared to the placebo group.

Evidence for the Study of Chronic Urticaria (Hives)

Histasin was evaluated in research exploring conditions characterized by fluctuating or episodic manifestations, such as chronic urticaria (hives). This evidence primarily comes from Randomized Controlled Trials (RCTs). The core objective of this research was to quantify the intensity and prevalence of outcomes related to inflammatory states, specifically the visible hives (weals) and associated pruritus (itching). Researchers used the Urticaria Activity Score (UAS). Studies report how symptoms evolved in the observed populations during the study period. The findings help contextualize how patients reported their experience regarding physical skin manifestations and quality of life.

Scope of Evidence: Duration, Special Groups, and Gaps

The clinical research provides insight into symptom patterns across its studied uses, with most primary efficacy studies relevant in trials assessing short-term or episodic symptom patterns over defined observation intervals. Research has also monitored measured outcomes over longer periods, up to six months. However, long-term effects are not fully established based on evidence exceeding this duration.

Research examined Histasin in specific patient groups, including children and adolescents with allergic rhinitis, and patients with asthma alongside their allergic rhinitis. However, the data for certain groups remain insufficient.

Finally, the research highlights areas where certainty remains low, such as the lack of full long-term data and the need for standardized patient-reported outcomes. Research provides context but not individual predictions.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Histasin (FAQ)

Q: How long does it typically take for Histasin to start working?

A: Studies on how the drug is absorbed indicate that the effects of Histasin typically begin quickly, within 20 to 42 minutes following an oral dose. This information is based on clinical pharmacokinetic data that monitors drug levels in the body.

Q: What is the difference between Histasin and other common medicines for similar conditions?

A: Histasin is classified as a second-generation H1-receptor antagonist, a type of antihistamine. The official product information notes that this class of medicine is designed to preferentially target histamine receptors outside the central nervous system, which is associated with a low potential for drowsiness compared to older, first-generation agents.

Q: Is Histasin safe to take every day for a long time?

A: Clinical studies have primarily assessed use for periods up to six months. Official safety information states that long-term effects beyond this duration are not fully established. Additionally, regulatory sources have noted that some patients have reported experiencing severe itching (pruritus) upon stopping the medicine after long-term daily use.

Q: What are the most commonly reported side effects of Histasin?

A: The official product labeling classifies drowsiness (somnolence), fatigue, headache, and dry mouth as the most commonly reported side effects. These effects may be experienced by more than 1 in 100 people and typically involve the nervous and gastrointestinal systems.

Q: Why is Histasin sometimes prescribed for an extended period?

A: Histasin is officially approved for managing conditions such as perennial allergic rhinitis (non-seasonal allergies) and chronic urticaria (hives). Because these conditions are often persistent or long-lasting, a regular, extended daily regimen may be described for managing symptoms.

Q: Is Histasin the same kind of drug as an antibiotic?

A: No, Histasin is scientifically categorized as a second-generation H1-receptor antagonist, which is a type of antihistamine used for allergies. It is not an antibiotic, which is a medicine used specifically to fight bacterial infections.

Q: What should I do if a side effect seems serious?

A: Official safety information documents very rare but serious adverse reactions, such as anaphylactic shock and convulsions. Regulatory documents emphasize that immediate emergency medical attention is warranted if a severe or life-threatening reaction is suspected.

Q: Can Histasin affect my ability to drive or operate machinery?

A: Yes, official safety information advises caution regarding activities that require full mental alertness, such as driving or operating machinery. This warning is in place because the common side effect of drowsiness (somnolence) may occur and could potentially impair performance.

Q: How long does Histasin stay in the body after the last dose?

A: The medicine is eliminated from the body primarily through the urine. In healthy adults, the mean time it takes for half of the drug to be eliminated, known as the elimination half-life, is approximately 8.3 hours.

Q: Is Histasin considered a controlled substance?

A: No, based on regulatory status, Histasin (Cetirizine Hydrochloride) is not classified as a controlled substance under federal law.

Q: Are there any known issues with taking Histasin with heart medication?

A: The official regulatory documents on drug interactions do not report a clinically significant pharmacokinetic interaction between Histasin and the heart medications that have been tested in formal studies.

Q: Does Histasin affect my blood pressure?

A: Reported common, uncommon, and rare side effects based on clinical trial data do not typically include changes in blood pressure. However, it is noted that the histamine system, which Histasin targets, has intrinsic links to cardiovascular function.

Q: Is Histasin similar to a common cold medicine?

A: Histasin is an antihistamine that is approved only for the symptomatic relief of allergic conditions, such as chronic hives and allergic rhinitis. It is not indicated for treating common cold or viral infections.

Q: Why do people say Histasin can cause dry mouth?

A: Dry mouth is one of the most common adverse reactions reported in clinical trials. While Histasin is a second-generation drug, its incidence was noted more frequently in patients taking the medicine than in those taking a placebo, and regulatory documents list it as a common side effect.

Q: Are there different forms of Histasin (e.g., tablet, liquid, capsule)?

A: Histasin is officially available in several dosage forms according to regulatory labeling. These include oral tablets, oral solution/liquid/syrup, and an intravenous (IV) solution intended for administration in acute clinical settings.

Q: What is the likelihood of having a severe allergic reaction to Histasin?

A: The likelihood of a severe allergic reaction, such as anaphylactic shock, is officially classified in regulatory documents as a 'Very Rare' event. This frequency means it is expected to occur in less than 1 in 10,000 patients.

Q: Is it important to take Histasin with food or on an empty stomach?

A: Official prescribing information states that Histasin may be taken with or without food. Regulatory data indicates that taking it with food can slightly delay the rate at which the drug is absorbed, but it does not change the total amount of medicine absorbed by the body.

Q: What are the potential long-term effects of using Histasin?

A: The long-term effects beyond the six-month duration of the main effectiveness studies are not fully established. Official safety communication highlights a risk of severe itching (pruritus) that can occur upon stopping the medicine after long-term use.

Q: Does Histasin help with anxiety or nervousness?

A: Histasin is an antihistamine approved only for allergic conditions and chronic hives. It is not indicated for the treatment of anxiety, nervousness, or any other psychiatric or neurological disorders.

Q: What does the name Histasin mean, or where does it come from?

A: Histasin is a brand name for the active ingredient Cetirizine. This ingredient is a synthetic chemical compound, specifically a piperazine derivative, that is a human metabolite of the older antihistamine hydroxyzine.

Q: Are there non-drug-related factors that can affect how well Histasin works?

A: Yes, official documents indicate that certain non-drug factors can influence how Histasin is processed. For example, the health of your kidneys (renal function) significantly affects how the drug is cleared from the body, and the presence of food can delay the rate of absorption.

How should Histasin be stored and disposed of?

How to Store and Dispose of Histasin?

The storage and disposal of Histasin (Cetirizine Hydrochloride) must strictly follow official regulatory requirements to maintain product stability and ensure safety.

Required Storage Conditions

Histasin must be stored at controlled room temperature, specifically between 20 C and 25 C (68 F and 77 F), with permitted short-term excursions. The medicine must be kept in its original container, which should be kept tightly closed and protected from both light and excessive moisture.

Child Safety and Disposal

It is a mandatory requirement to store Histasin out of the sight and reach of children and pets. For disposal, unused or expired product should be discarded using authorized drug take-back programs or by following regulatory guidance, such as mixing the product with an undesirable substance before sealing and placing it in the household trash. The product must not be flushed down a toilet or poured into wastewater.

Histasin